Form 4: Zura Bio Ltd: Officer Howell Reports Share Disposal for Tax Obligations

Michael Howell, Chief Scientific Officer of Zura Bio Ltd, reports the disposal of shares to cover tax obligations related to restricted stock units.

Summary

• Michael Howell, Chief Scientific Officer and Head of Translational Science at Zura Bio Ltd, filed a Form 4.
• The form reports a transaction on May 18, 2024, where 9,860 Class A ordinary shares were disposed of at a price of $6.05 per share to satisfy tax withholding obligations related to the settlement of restricted stock units.
• Following the transaction, Howell directly owns 104,535 Class A ordinary shares.
• Howell also indirectly owns 7,987 Class A ordinary shares through Mountaineer Biosciences, Inc., where he is the Co-Founder and has voting and disposal power over the shares.
• Howell disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment.

Management Comments

• The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
• This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the disposal of shares by an officer to cover tax obligations.

Key Dates